|
|||||
|
|
The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30?kg/m2 in Spain |
|
| Abstract: | |
| Keywords: | Diabetes Cost-effectiveness Spain Exenatide Insulin glargine Type 2 diabetes |